255 related articles for article (PubMed ID: 30015065)
1. Patterns of glucose-lowering medication use in patients with type 2 diabetes and heart failure. Insights from the Diabetes Collaborative Registry (DCR).
Arnold SV; Echouffo-Tcheugui JB; Lam CSP; Inzucchi SE; Tang F; McGuire DK; Goyal A; Maddox TM; Sperling LS; Fonarow GC; Masoudi FA; Kosiborod M
Am Heart J; 2018 Sep; 203():25-29. PubMed ID: 30015065
[TBL] [Abstract][Full Text] [Related]
2. Assessing use of patient-focused pharmacotherapy in glycemic management through the Diabetes Collaborative Registry (DCR).
Arnold SV; McGuire DK; Inzucchi SE; Tang F; Mehta SN; Lam CSP; Goyal A; Sperling LS; Wong ND; Hammar N; Fenici P; Kosiborod M
J Diabetes Complications; 2018 Nov; 32(11):1035-1039. PubMed ID: 30177468
[TBL] [Abstract][Full Text] [Related]
3. Contemporary use of cardiovascular risk reduction strategies in type 2 diabetes. Insights from the diabetes collaborative registry.
Arnold SV; Gosch K; Kosiborod M; Wong ND; Sperling LS; Newman JD; Gamble CL; Hamersky C; Rajpura J; Vaduganathan M
Am Heart J; 2023 Sep; 263():104-111. PubMed ID: 37164146
[TBL] [Abstract][Full Text] [Related]
4. Understanding Contemporary Use of Thiazolidinediones.
Arnold SV; Inzucchi SE; Echouffo-Tcheugui JB; Tang F; Lam CSP; Sperling LS; Kosiborod M
Circ Heart Fail; 2019 Jun; 12(6):e005855. PubMed ID: 31129998
[TBL] [Abstract][Full Text] [Related]
5. Effects of sodium glucose cotransporter type 2 inhibitors on heart failure.
Nassif ME; Kosiborod M
Diabetes Obes Metab; 2019 Apr; 21 Suppl 2():19-23. PubMed ID: 31081589
[TBL] [Abstract][Full Text] [Related]
6. Heart failure in the patient with diabetes: Epidemiology, aetiology, prognosis, therapy and the effect of glucose-lowering medications.
Bell DSH; Goncalves E
Diabetes Obes Metab; 2019 Jun; 21(6):1277-1290. PubMed ID: 30724013
[TBL] [Abstract][Full Text] [Related]
7. Quality of Care Among Patients with Diabetes and Cerebrovascular Disease. Insights from The Diabetes Collaborative Registry.
Echouffo-Tcheugui JB; Turchin A; Rosenson RS; Fonarow GC; Goyal A; de Lemos JA; Arnold SV
Am J Med; 2022 Nov; 135(11):1336-1341. PubMed ID: 35872090
[TBL] [Abstract][Full Text] [Related]
8. Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification.
Lawson CA; Jones PW; Teece L; Dunbar SB; Seferovic PM; Khunti K; Mamas M; Kadam UT
JACC Heart Fail; 2018 Jan; 6(1):18-26. PubMed ID: 29032131
[TBL] [Abstract][Full Text] [Related]
9. The influence of anti-hyperglycemic drug therapy on cardiovascular and heart failure outcomes in patients with type 2 diabetes mellitus.
Asleh R; Sheikh-Ahmad M; Briasoulis A; Kushwaha SS
Heart Fail Rev; 2018 May; 23(3):445-459. PubMed ID: 29270818
[TBL] [Abstract][Full Text] [Related]
10. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
Sartipy U; Dahlström U; Fu M; Lund LH
JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
[TBL] [Abstract][Full Text] [Related]
11. Heart Failure With Type 2 Diabetes Mellitus: Association Between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction.
Lin SN; Phang KK; Toh SH; Chee KH; Zaman Huri H
Front Endocrinol (Lausanne); 2020; 11():448. PubMed ID: 32754118
[No Abstract] [Full Text] [Related]
12. Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetes.
Fitchett DH; Udell JA; Inzucchi SE
Eur J Heart Fail; 2017 Jan; 19(1):43-53. PubMed ID: 27653447
[TBL] [Abstract][Full Text] [Related]
13. Heart failure documentation in outpatients with diabetes and volume overload: an observational cohort study from the Diabetes Collaborative Registry.
Arnold SV; Jones PG; Beasley M; Cordova J; Goyal A; Fonarow GC; Seman L
Cardiovasc Diabetol; 2020 Dec; 19(1):212. PubMed ID: 33308233
[TBL] [Abstract][Full Text] [Related]
14. Type 2 diabetes and heart failure: insights from the global DISCOVER study.
Arnold SV; Khunti K; Bonnet F; Charbonnel B; Chen H; Cid-Ruzafa J; Cooper A; Fenici P; Gomes MB; Hammar N; Ji L; Luporini-Saraiva G; Medina J; Nicolucci A; Ramirez L; Shestakova MV; Shimomura I; Surmont F; Tang F; Vora J; Watada H; Kosiborod M;
ESC Heart Fail; 2021 Apr; 8(2):1711-1716. PubMed ID: 33570253
[TBL] [Abstract][Full Text] [Related]
15. Use of sodium-glucose co-transporter-2 inhibitors in patients with and without type 2 diabetes: implications for incident and prevalent heart failure.
Butler J; Handelsman Y; Bakris G; Verma S
Eur J Heart Fail; 2020 Apr; 22(4):604-617. PubMed ID: 31926059
[TBL] [Abstract][Full Text] [Related]
16. Contemporary choice of glucose lowering agents in heart failure patients with type 2 diabetes.
Martens P; Janssens J; Ramaekers J; Dupont M; Mullens W
Acta Cardiol; 2020 Jun; 75(3):211-217. PubMed ID: 30736724
[No Abstract] [Full Text] [Related]
17. [Effect of strict glycemic control on clinical state and course of the disease in patients with chronic heart failure and type II diabetes mellitus. Results of the REMBO "rational effective multicomponent therapy in the struggle against diabetes mellitus in patients with congestive heart failure" study].
Lapina IuV; Filatov DN; Mareev VIu; Narusov OIu; Bolotina MG; Shestakova MV; Masenko VP; Litonova GN; Baklanova NA; Belenkov IuN
Kardiologiia; 2008; 48(9):17-27. PubMed ID: 18991816
[TBL] [Abstract][Full Text] [Related]
18. Utilization rates and predictors of sodium glucose cotransporter 2 inhibitor use in patients with heart failure with or without type 2 diabetes.
Bermudez SR; Anderson JR; Bos AJ; Ray GM
Am J Health Syst Pharm; 2023 Dec; 80(24):1787-1795. PubMed ID: 37551996
[TBL] [Abstract][Full Text] [Related]
19. Effect of glucose-lowering therapies on heart failure.
Nassif M; Kosiborod M
Nat Rev Cardiol; 2018 May; 15(5):282-291. PubMed ID: 29368701
[TBL] [Abstract][Full Text] [Related]
20. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.
Löfman I; Szummer K; Dahlström U; Jernberg T; Lund LH
Eur J Heart Fail; 2017 Dec; 19(12):1606-1614. PubMed ID: 28371075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
